In October, Octapharma announced that it is accepting applications for the Octapharma 25th Anniversary Grants Program through April 1, 2011. The program supports clinical or pre-clinical research focused on human protein therapies in coagulation disorders, immunotherapy, intensive care and emergency medicine. The grants, which are available to U.S.-based researchers, are administered by Octapharma USA.
Octapharma AG, which manufactures plasma products, launched the grants program last year in celebration of the company’s 25th anniversary. Applications, which are only accepted online at www.octapharmagrants.com, will be evaluated by the Octapharma Grants Committee.
Octapharma has also launched a comprehensive new Web site related to Wilate®, the company’s plasma-derived factor replacement therapy developed for von Willebrand disease (VWD). The site provides healthcare professionals and patients with easily accessible information, news and updates. The Web site can be found at: www.wilateusa.com.
Sources: PR Newswire, October 4 & 14, 2010